Abstract
The relationship between peripheral blood lymphocyte levels and monitoring and assessment of prognosis of patients with large-bowel cancer has been assessed. There does not appear to be a correlation between the absolute lymphocyte count and the state of disease. Furthermore, the preresection and postresection lymphocyte levels do not accurately predict the likelihood of recurrent cancer subsequently developing, and the serial monitoring of patients with peripheral blood lymphocyte levels adds no important new information to clinical follow-up.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Evans J, Vana J, Aronoff B, Baker M, Murphy G. Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons. Ann Surg 1978;188:716–20.
Gray B, Walker C, Barnard R. Value of serial carcinoembryonic antigen: determinations for early detection of recurrent cancer. Med J Aust 1981;1:177–8.
Walker C, Gray B. Acute phase reactant proteins and carcinoembryonic antigen in cancer of the colon and rectum. Cancer (In press).
Gray BN, Walker C, Barnard R, Bennett RC. Tennessee antigen: its value in the monitoring of patients with colorectal cancer. Dis Colon Rectum 1982;25:542–4.
Slater G, Kim U, Papatestas A, Aufses A. Peripheral lymphocytes in carcinoma of the colon and rectum. Surg Gynecol Obstet 1979; 149:719–21.
Kim U, Papatestas A, Aufses A. Prognostic significance of peripheral lymphocyte counts and carcinoembryonc antigens and colorectal carcinoma. J Surg Oncol 1976;8:257–62.
Author information
Authors and Affiliations
About this article
Cite this article
Gray, B.N., Walker, C. & Bennett, R.C. Peripheral blood lymphocyte levels in large-bowel cancer. Dis Colon Rectum 26, 433–434 (1983). https://doi.org/10.1007/BF02556520
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02556520